Wells Fargo’s Mirum Pharmaceuticals MIRM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.1M | Buy |
198,160
+164,492
| +489% | +$8.37M | ﹤0.01% | 1716 |
|
|
2025
Q1 | $1.52M | Sell |
33,668
-6,858
| -17% | -$309K | ﹤0.01% | 3010 |
|
|
2024
Q4 | $1.68M | Sell |
40,526
-67,501
| -62% | -$2.79M | ﹤0.01% | 2926 |
|
|
2024
Q3 | $4.21M | Buy |
108,027
+69,913
| +183% | +$2.73M | ﹤0.01% | 2236 |
|
|
2024
Q2 | $1.3M | Buy |
38,114
+30,239
| +384% | +$1.03M | ﹤0.01% | 3009 |
|
|
2024
Q1 | $198K | Buy |
7,875
+869
| +12% | +$21.8K | ﹤0.01% | 4113 |
|
|
2023
Q4 | $207K | Sell |
7,006
-23,213
| -77% | -$685K | ﹤0.01% | 4060 |
|
|
2023
Q3 | $955K | Sell |
30,219
-541
| -2% | -$17.1K | ﹤0.01% | 3119 |
|
|
2023
Q2 | $796K | Buy |
30,760
+12,835
| +72% | +$332K | ﹤0.01% | 3429 |
|
|
2023
Q1 | $431K | Buy |
+17,925
| New | +$431K | ﹤0.01% | 3703 |
|
|
2022
Q4 | – | Sell |
-737
| Closed | -$16K | – | 7266 |
|
|
2022
Q3 | $16K | Buy |
737
+284
| +63% | +$6.17K | ﹤0.01% | 5178 |
|
|
2022
Q2 | $9K | Buy |
+453
| New | +$9K | ﹤0.01% | 5503 |
|
|
2022
Q1 | – | Sell |
-21
| Closed | – | – | 7013 |
|
|
2021
Q4 | $0 | Sell |
21
-282
| -93% | – | ﹤0.01% | 7005 |
|
|
2021
Q3 | $6K | Sell |
303
-31
| -9% | -$614 | ﹤0.01% | 6004 |
|
|
2021
Q2 | $6K | Sell |
334
-2,166
| -87% | -$38.9K | ﹤0.01% | 5951 |
|
|
2021
Q1 | $50K | Sell |
2,500
-16,538
| -87% | -$331K | ﹤0.01% | 5466 |
|
|
2020
Q4 | $332K | Buy |
19,038
+13,752
| +260% | +$240K | ﹤0.01% | 4707 |
|
|
2020
Q3 | $101K | Sell |
5,286
-1,212
| -19% | -$23.2K | ﹤0.01% | 5065 |
|
|
2020
Q2 | $126K | Buy |
6,498
+2,820
| +77% | +$54.7K | ﹤0.01% | 4921 |
|
|
2020
Q1 | $51K | Buy |
3,678
+3,443
| +1,465% | +$47.7K | ﹤0.01% | 5109 |
|
|
2019
Q4 | $5K | Buy |
235
+18
| +8% | +$383 | ﹤0.01% | 5664 |
|
|
2019
Q3 | $2K | Buy |
+217
| New | +$2K | ﹤0.01% | 5743 |
|